Affordable Access

Effect of platelet derived growth factor receptor-β inhibition with STI571 on radioimmunotherapy

Authors
  • Janina Baranowska-Kortylewicz*
  • Michio Abe
  • Kristian Pietras
  • Zbigniew P. Kortylewicz
  • Takashi Kurizaki
  • Jessica Nearman
  • Janna Paulsson
  • R. Lee Mosley
  • Charles A. Enke
  • Arne Östman
Publication Date
Sep 01, 2005
Source
PMC
Keywords
Disciplines
  • Medicine
License
Unknown

Abstract

While radioimmunotherapy of hematological malignancies has evolved into a viable treatment option, the responses of solid tumors to RADIOIMMUNOTHERAPY are discouraging. The likely cause of this problem is the interstitial hypertension inherent to all solid tumors.

Report this publication

Statistics

Seen <100 times